Full-Time

Shift Manager Suite 1

Posted on 7/4/2025

Deadline 7/14/25
Pfizer

Pfizer

10,001+ employees

Develops and manufactures biopharmaceutical products

No salary listed

Senior

Visakhapatnam, Andhra Pradesh, India

In Person

Category
Generalist Operations
Quality Control & Compliance
Operations & Logistics
Requirements
  • High school diploma (or equivalent) with 8+ years of experience or associate’s degree with 6+ years of experience or BA/BS with 2+ years of experience or MBA/MS with any years of relevant experience
  • Proven record of problem-solving and decision-making skills
  • Demonstrated application of process improvement tools
  • Strong people management experience
  • Effective written and oral communication skills
  • Experience in pharmaceutical manufacturing or a related field
  • Ability to manage multiple projects and ongoing work activities
Responsibilities
  • Lead people, technology, and financial resources to achieve desired outcomes.
  • Actively share knowledge and encourage a culture of continuous learning and improvement.
  • Identify and develop innovative concepts for process or product improvements, taking calculated risks to achieve results.
  • Recognize and address development needs, creating opportunities for colleagues' growth.
  • Manage the performance of direct and indirect reports, providing mentorship and support to achieve the business objectives.
  • Ensure adherence to Standard Operating Procedures, batch records, Current Good Manufacturing Practices, and plant protocols.
  • Lead investigations into equipment failures, implement corrective and preventive actions, and maintain clear communication to prevent reoccurrence.
Desired Qualifications
  • Strong leadership capabilities
  • Experience with regulatory compliance and quality assurance
  • Proficiency in project management tools and methodologies
  • Ability to influence and lead cross-functional teams
  • Ability to mentor and develop direct reports
  • Ability to foster a culture of safety and continuous improvement

Pfizer is a biopharmaceutical company that focuses on creating and producing healthcare products, including medicines and vaccines. The company conducts extensive research and development to discover new treatments, which are then manufactured and sold globally. Pfizer's products include vaccines, oncology treatments, and other specialized medicines, with a significant role in developing a vaccine for COVID-19 in partnership with BioNTech. What sets Pfizer apart from its competitors is its strong commitment to public health, demonstrated by efforts to provide vaccines to underserved populations and a continuous expansion of its product portfolio through new approvals. The goal of Pfizer is to improve health outcomes worldwide by delivering effective healthcare solutions.

Company Size

10,001+

Company Stage

IPO

Headquarters

New York City, New York

Founded

1849

Simplify Jobs

Simplify's Take

What believers are saying

  • €3.3 billion bond offering provides capital for research initiatives or acquisitions.
  • Starboard Value's $1 billion stake suggests potential strategic changes to enhance shareholder value.
  • Backing Promise Bio aligns with expanding into new therapeutic areas like autoimmune diseases.

What critics are saying

  • Increased competition from emerging biotech companies could impact Pfizer's market share.
  • Slowdown in COVID-19 vaccine demand poses a risk to Pfizer's revenue streams.
  • Shift towards AI-driven drug discovery may disrupt traditional R&D processes at Pfizer.

What makes Pfizer unique

  • Pfizer's partnership with BioNTech led to a highly effective COVID-19 vaccine.
  • Pfizer's investment in AI disease models enhances drug discovery and development.
  • Pfizer's strategic interest in TCR-based immunotherapies diversifies its oncology portfolio.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

401(k) Retirement Plan

401(k) Company Match

Paid Vacation

Paid Sick Leave

Paid Holidays

Hybrid Work Options

Relocation Assistance

Company News

Stroock & Stroock & Lavan LLP
May 20th, 2025
Pfizer Completes €3.3 Billion Bond Offering

Simpson Thacher represented the underwriters, led by Goldman Sachs & Co. LLC, BNP PARIBAS, HSBC, Mizuho, among others in connection with a registered offering of €3.3 billion in Notes by Pfizer, Inc.’s (“Pfizer”) wholly-owned subsidiary, Pfizer Netherlands International Finance B.V. (the “Issuer”). The Notes were issued in four series with maturities ranging from 2029 to 2045, with proceeds intended to be used for general corporate purposes. The Notes are fully and unconditionally guaranteed on a senior unsecured basis by Pfizer.

Finsmes
Mar 5th, 2025
Trimtech Therapeutics Raises $31M in Seed Funding

Trimtech Therapeutics, a Cambridge, UK-based biotech company harnessing targeted protein degradation (TPD) for the treatment of neurodegenerative diseases, raised $31M in Seed funding

Business Wire
Jan 16th, 2025
Normunity Closes $75 Million Series B Financing to Advance Lead Drug Program Into the Clinic and Broaden Pipeline of Novel Anti-Cancer Therapies Targeting Untapped Drug Mechanisms

Normunity, a biotechnology company creating novel anti-cancer therapies, today announced that it has closed a Series B financing for $75 million. The

TechCrunch
Oct 23rd, 2024
Promise Bio exits stealth backed by Pfizer and AstraZeneca | TechCrunch

The company has made it easier to test for different protein modifications which are critical to the treatment of autoimmune diseases.

The Wall Street Journal
Oct 7th, 2024
Exclusive | Activist Starboard Value Takes $1 Billion Stake in Pfizer

The drugmaker’s shares have slumped as demand for Covid-19 vaccines and treatments had slowed.

INACTIVE